Pfizer’s coronavirus vaccine is more than 90 percent effective | Flash News PK


Pfizer’s coronavirus vaccine is more than 90 percent effective




The announcement is a major victory in the fight against the disease, which has killed more than a million people.


Pfizer says the experimental COVID-19 vaccine is over 90% effective, a major breakthrough in the fight against epidemics that have killed more than a million people, boosted the global economy and affected daily lives. It is said.


According to a provisional analysis by an independent data monitoring committee, the cornavirus vaccine developed by leading pharmaceutical giant Pfizer and German biotechnology company Biotech, discovered on Sunday, was more than 90% effective.


Pfizer and its German partner Biotech SE are the first drugmakers to publish successful data from large-scale clinical trials of the cornavirus vaccine. The companies say they have yet to find serious safety concerns and hope that 16-85 year olds will seek US permission to use the vaccine this month.


Read More:- 6G Network is already in shape | The world's first 6G test satellite launched | Flash News Pk


If the number of doses is allowed, the number of doses will initially be limited, leaving many questions, including how long the vaccine provides protection. However, the news hopes that other co-vaccines in development will also be available.


“Today is a great day for science and humanity,” said Albert Bolera, President and CEO of Pfizer.


“We are at the stage of our vaccine development agenda when the world must set new records and fight to reopen hospitals and economies that are close to the capabilities of the most vulnerable.


Pfizer needs safety data for about half to two months from study participants scheduled for later this month.


The initial appearance of the current trial gives a definitive first look at the actual performance of one of the four cornaviruses in the late stages of trials in the United States. The unprecedented struggle to develop a vaccine that helps eliminate the disease is the strongest signal it can break the record of any scientific dynamic.


Read More:- Central Bank’s Governor Sacked by President Erdogan as lira hit lowest in eight years  | Flash News PK


The MSCI index on the global stock market is at an all time high since its announcement. Pfizer stock rose 6% in New York and US biotech shares rose 18%.


"I am close to happiness," said Bill Gruber, one of Pfizer's top scientists, in an interview. "This is a great day for public health and health and the ability to remove all of us from the plight of each of us.


Gloria Tarani, professor of anti-inflammatory disease at the University of Sepensa in Rome, Italy, described the result as "an incredible improvement" because she predicted that the vaccine would be effective in only 75% of subjects.


“But the unanswered question is how much will it cost and how few rich countries can support it?


Pfizer and Biotechnology signed a $ 1.95 billion contract with the US government to deliver 100 million doses of the vaccine later this year. We also have supply contracts with the European Union (EU), UK, Canada, and Japan.

The new vaccines will be particularly reassuring for Europeans - the current axis of the disease and the widespread bans in the region.


Italy was approaching a full lockdown, experts warned of the hospital's dire situation.


"There is no doubt that the situation is largely out of control," said Massimo Gali, head of the infectious diseases department at Sco Hospital in Milan.


And the news kept coming, and Russia tested the government's commitment to keep a daily infection record and then not impose new lockdowns.


Read More:- First Flying Car Prototype Takes to the Skies After Driving the Road by Klein Vision | Flash News PK


Hungary is currently the worst-hit country in terms of population deaths, and the government announced new national sanctions on Wednesday.


To save time, companies began to prepare vaccines before checking whether they were effective. We plan to produce up to 50 million pieces of food this year, or 25 million pieces this year.


Pfizer said it expects to produce 1.3 billion vaccines in 2021.




The giant American pharmaceutical company said that the interim analysis was conducted after 94 participants in the "Covid-19" trial, examined the number of people who received the vaccine compared to a placebo.


The company did not specify exactly how many people who contracted the disease received the vaccine. However, more than 90 percent of the effectiveness means that no more than eight of the 94 people who have contracted CONVID-19 have received the vaccine, which was given as two injections approximately three weeks apart.


The efficacy rate is much higher than the 50 percent effectiveness required by the US Food and Drug Administration for the Coronavirus vaccine.


To confirm the efficacy rate, Pfizer stated that it will continue the trial until there are 164 cases of COVID-19 among the participants. Given the recent surge in infection rates in the United States, Gruber said, that number could be reached in early December.


The data has not yet been peer-reviewed or published in a medical journal. Pfizer has said it will do so once it obtains the results of the entire trial.


The global race to get a vaccine has seen rich countries sign billions of dollars in supply agreements with pharmaceutical manufacturers such as Pfizer, AstraZeneca Plc and Johnson Johnson, raising questions about when average incomes and poor countries will be able to get vaccinated.


The United States' pursuit of a vaccine has been the Trump administration's central response to the pandemic. The United States has the largest known number of cases and deaths from COVIDE-19 in the world, with more than 10 million infections and more than 237,000 deaths.


President Donald Trump has repeatedly emphasized that his administration will likely determine a successful vaccine in time for last Tuesday's presidential election. On Saturday, his Democratic challenger, Joe Biden, was declared the winner.


Vaccines are seen as essential tools to help end the health crisis that has shut down businesses and left millions of people out of work. Millions of children whose schools closed in March are still participating in distance learning programs.


Before information on vaccines emerged, the World Health Organization (WHO) warned again against complacency about a disease that has killed more than 1.25 million people worldwide.


We may get tired of Covid-19, WHO chief Tedros Adhanom Ghebreyesus said. But he never gets tired of us

Dozens of drug manufacturers and research groups around the world are racing to develop vaccines against the Covid-19 company, which on Sunday has surpassed 50 million infections since the new coronavirus was first reported late last year in China.


Source:-  News Agencies


Read More:- Flying V The Futuristic Aircraft makes successful maidan flight | Flash News PK




Post a Comment

Previous Post Next Post